NCT03827642 - A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

May 6, 2018

Study Completion Date

May 6, 2018

Conditions

Healthy Volunteer

Interventions

DRUG

Treatment A: Naloxone Nasal Spray

Participants received naloxone nasal spray following a 10 hour fast.

DRUG

Treatment B: Naloxone Nasal Spray

Participants received naloxone nasal spray following a 10 hour fast.

DRUG

Treatment C: Naloxone HCl Intravenous (IV) Injection

Participants received naloxone HCl IV injection following a 10 hour fast.

DRUG

Treatment D: Naloxone HCl Intramuscular (IM) Injection

Participants received naloxone HCl IM injection following a 10 hour fast.

Trial Locations (1)

Worldwide Clinical Trials, San Antonio